简体中文
Français
Deutsch
日本語
Español
LabCorp
Careers
Investigators
Order a Kit
Trial Share
CT Portal
Clinical Trials
Choose Language
Industry Solutions
Industry Solutions
Back
Drug Development
Drug Development
Back
By Phase
By Phase
Back
Covance MarketPlace
By Service
By Therapeutic or Specialty Area
By Therapeutic or Specialty Area
Back
Dermatology
Ophthalmology
Pediatrics
By Geography
By Molecule or Product Type
By Molecule or Product Type
Back
Cell and Gene Therapy Solutions
Healthcare
Healthcare
Back
Commercialization
Informatics
Informatics
Back
Xcellerate® Clinical Trial Optimization®
Oncology
Oncology
Back
Preclinical
Preclinical
Back
Cell Lines
Tumor Models
CAR T
In Vitro
Posters
Clinical
Clinical
Back
Meet the Team
Patient Recruitment
Immuno-Oncology
Immuno-Oncology
Back
Preclinical
Education
Education
Back
Top 5 Design Considerations for Preclinical Immuno-oncology Studies
Top 5 Models for Immuno-oncology Studies
Events
Events
Back
Precision Medicine Applications in Oncology Webinar Series
Webinars
IND/CTA
Lung Disease
Lung Disease
Back
Preclinical
Clinical
Resources
Inhalation
Device
Services
Services
Back
Drug Analysis Services
Drug Analysis Services
Back
Bioanalytical Laboratory Solutions & Services
Bioanalytical Laboratory Solutions & Services
Back
LC-MS Immunoanalytical Solutions
Specialty LC-MS Support
Discovery Bioanalysis
Vaccine Analysis
Analytical Methods
Bioanalysis Education Center
DMPK
DMPK
Back
In Vitro Metabolism
In Vivo Metabolism
Metabolite Identification (MetID)
DMPK Events
Modeling & In Silico
Custom Antibody Reagents
Discovery & Lead Optimization
Discovery & Lead Optimization
Back
Non-GLP Tox & Pharmacology
Non-GLP Tox & Pharmacology
Back
Core Lead Optimization Toxicology Services
Safety Assessment
Disease Models
Disease Models
Back
Comprehensive Leukocyte Quantitation
Oncology Cell Line Assays
PK/TK Study & Analysis
Nonclinical Imaging
Nonclinical Imaging
Back
Computed Tomography (CT) Services
Bioluminescence Imaging
Image Analysis Services
Positron Emission Services
Radiation
Flow Cytometry
Vaccines
Product Testing
Product Testing
Back
Crop Protection
Crop Protection
Back
Crop Protection Education Center
Human Safety
Regulatory
Endocrine
Physical Chemistry
Environmental
Locations
Chemical
Chemical
Back
Physical Chemistry
Human Safety
Environmental
Endocrine
Regulatory
Education
Locations
Locations
Locations
Back
Shanghai
Ann Arbor
Madison
Harrogate
Denver
Eye
Greenfield, IN
Huntingdon
Münster
Shardlow
Somerset
Pathology
Pathology
Back
Anatomic
Clinical
Specialty
Specialty
Back
IHC
TEM
Manufacturing Support
Manufacturing Support
Back
CMC Analytical
CMC Analytical
Back
BIOCMC Analytical Solutions Education Center
Toxicology
Toxicology
Back
General
General
Back
SEND - Standard for the Exchange of Nonclinical Data
Core services
Abuse liability
Infusion
Juvenile
Neurotoxicity
NHP
Ocular
Genetic
Genetic
Back
Regulatory
Screening
Multi-endpoint
Immunotoxicology
Pharmacology
Pharmacology
Back
Cardiovascular (in vitro & vivo)
ICH Core Battery
ICH Supplemental
Discovery Support
Neurotoxicology
Infusion
Drug Abuse Education Center
DART
DART
Back
SEG I
SEG II
SEG III
ePPND
Juvenile
Specialty Techniques
Infusion
SEND 3.1
SEND 3.1
Back
SEND Education Center
Administration Routes
Administration Routes
Back
Inhalation
Consulting & Partnering
Consulting & Partnering
Back
Alliance Management
Early Phase Development Solutions
Covance MarketPlace
Drug Development Consulting
Data & Technology Solutions
Data & Technology Solutions
Back
Data Capabilities
Design Better Studies
Improve Study Recruitment
Reduce Study Risk
Gain Operational Insights
Ensure Data Quality
Access Central Laboratory Information
Empower Your Data
Maximize Product Access
Transform Patient Safety
Clinical Development
Clinical Development
Back
Clinical Pharmacology
Clinical Pharmacology
Back
Clinical Pharmacology Education Center
Early Clinical / Phase IIa
Early Clinical / Phase IIa
Back
Clinical Research Unit Virtual Tours
Phase IIb / III Services
Clinical Data Management Analysis and Reporting
Regulatory Services
Phase IV
Clinical Research Unit Virtual Tours
Clinical-Biotech
Decentralized Clinical Trials
Decentralized Clinical Trials
Back
Decentralized Clinical Trials (DCT) Education Center
Clinical Trial Laboratory Services
Clinical Trial Laboratory Services
Back
Central Labs
Central Labs
Back
Companion Diagnostics
SpecimINSIGHT™/GlobalCODE®
Patient Service Centers
GlobalCODE®
Specialty Testing
Specialty Testing
Back
Flow Cytometry
Biomarkers
Vaccines
Expanded Lab Management Solutions
Precision Medicine
Precision Medicine
Back
Biomarker Solutions
Biomarker Solution Center
Companion Diagnostics
Genomics Solutions
Cell and Gene Therapy Solutions
Immuno-Oncology
Bioanalytical
Bioanalytical
Back
Validated Assays
Bioanalysis Education Center
CMC
CMC
Back
BIOCMC Analytical Solutions Education Center
Functional Service Provider (FSPx)
Functional Service Provider (FSPx)
Back
FSP Education Center
Commercialization
Commercialization
Back
Access and Strategy
Evidence Generation
Value Communication
Patient Support Services
Patient Support Services
Back
Patient Access Programs 2020 Events
Phase IV Solutions
Patient Safety and Pharmacovigilance Services
Patient Safety and Pharmacovigilance Services
Back
PV Services
Aggregate Reporting and Safety Writing
Signal Detection and Risk Management
Patient Safety Consulting
Drug Safety Technology
Patient Safety Solutions Resource Center
Pharmacovigilance Automation
Clients
Clients
Back
Biotech
Biotech
Back
Partner
Approach
Value
Transition
Contact
The Hub
Global Pharma
Clinical Trial Investigators
Clinical Trial Investigators
Back
Dry Ice
Order a Kit
Become an Investigator
Accreditations and Certifications
Current Investigator Resources
Current Investigator Resources
Back
Courier Numbers
Label: UPS Express Critical
Order: Dry Ice
Privacy Statement: Institution
Privacy Statement: Investigator
Privacy Statement: Study Staff
Videos: Packing & Shipping
Videos: Sample Collection
FAQs
Participate in a Trial
Device / Diagnostics
Device / Diagnostics
Back
Strategic Approach
Regulatory
Preclinical
Clinical
Post-Market
Education Center
Consultant Connection
Device
Articles & Research
Articles & Research
Back
Blog
Knowledge Library
Knowledge Library
Back
KL Detail
KL Search Page Custom
About Us
About Us
Back
About Covance
Corporate Responsibility
Insightful Partners
Relentless Collaborators
Animal Welfare
Brexit Update
Contact
LabCorp
Careers
Investigators
Order a Kit
Trial Share
CT Portal
Clinical Trials
<
Industry Solutions
Services
Clients
Device
Articles & Research
About Us
Contact
>
By Therapeutic or Specialty Area
Cardiovascular
Dermatology
Diabetes, Endocrinology and Nephrology
Immuno-Oncology
Infectious Diseases
Inflammation
Neuroscience
Non-Alcoholic Steatohepatitis (NASH)
Oncology
Rare Disease and Orphan Drugs
Ophthalmology
Pediatrics
Respiratory & Pulmonary
By Phase
Research
Preclinical
Clinical (Phase I - III)
Phase IV
MarketPlace
By Geography
By Molecule or Product Type
Biologics Solutions
Biomarkers
Small Molecule Solutions
Biosimilars Development Solutions
Cell & Gene Therapy Solutions
Data & Technology Solutions
Data Capabilities
Design Better Studies
Improve Study Recruitment
Reduce Study Risk
Gain Operational Insights
Ensure Data Quality
Access Central Laboratory Information
Empower Your Data
Maximize Product Access
Transform Patient Safety
Device & Diagnostics
Functional Service Provider (FSP)
Commercialization
Market Access and Phase IV Solutions
Drug Analysis Services
Bioanalytical Laboratory Solutions & Services
DMPK
Custom Antibody Reagents
Discovery & Lead Optimization
Non-GLP Tox & Pharmacology
Disease Models
PK/TK Study & Analysis
Nonclinical Imaging
Radiation
Flow Cytometry
Vaccines
Product Testing
Crop Protection
Chemical
Locations
Pathology
Anatomic
Clinical
Specialty
Manufacturing Support
CMC Analytical
Toxicology
General
Genetic
Immunotoxicology
Pharmacology
DART
SEND 3.1
Administration Routes
Inhalation
Consulting & Partnering
Alliance Management
Early Phase Development Solutions
Covance MarketPlace
Drug Development Consulting
Data & Technology Solutions
Data Capabilities
Design Better Studies
Improve Study Recruitment
Reduce Study Risk
Gain Operational Insights
Ensure Data Quality
Access Central Laboratory Information
Empower Your Data
Maximize Product Access
Transform Patient Safety
Clinical Development
Clinical Pharmacology
Early Clinical / Phase IIa
Phase IIb / III Services
Clinical Data Management Analysis and Reporting
Regulatory Services
Phase IV
Clinical Research Unit Virtual Tours
Clinical-Biotech
Decentralized Clinical Trials
Clinical Trial Laboratory Services
Central Labs
Specialty Testing
Precision Medicine
Bioanalytical
CMC
Functional Service Provider (FSPx)
FSP Education Center
Commercialization
Access and Strategy
Evidence Generation
Value Communication
Patient Support Services
Phase IV Solutions
Patient Safety and Pharmacovigilance Services
Biotech
The Hub
Global Pharma
Clinical Trial Investigators
Participate in a Trial
Device / Diagnostics
Consultant Connection
Legacy Chiltern TrialShare
Legacy Chiltern CT Portal
Quick Links
Order a Kit
Become an Investigator
Accreditations
Tools and Resources
Investigator FAQs
DocuSign SA Root CA Certificates
Our Company
About Covance
Upcoming Events & Webinars
Press & News
Blog
Brexit Update
Our Values
Corporate Responsibility
Animal Welfare
Insightful Partners
Relentless Collaborators
Covance Innovation
Resource Centers
Bioanalysis
Biopharm CMC
Biosimilars
Cell and Gene Therapy
Clinical Pharmacology
Immuno-Oncology
Infectious Diseases
Inflammation
Oncology
NASH Solutions
Rare Disease and Orphan Drugs
SEND
Vaccines
Contact Us
Contact Us Form
Suppliers
Clinical Trials
Participate in a Clinical Trial
Call Us
The Americas
+1.888.COVANCE (+1.888.268.2623)
1.609.452.4440
Europe/Africa
+00.800.2682.2682
+44.1423.500888
Asia/Pacific
+800.6568.3000
+65.6.5686588
Global Office Locations
Connect with Covance
Sign up for Covance news and emails
Events & Webinars
Media Relations
Request an Interview
Request a Speaker
Investigators
Kit Ordering
Investors
Investor Relations
Job Seekers
Covance Careers
Home
Covance Sitemap
Covance Sitemap
Sitemap List
Industry Solutions
Drug Development
Drug Development Process by Phase | Covance
Proof of Concept Study in Clinical Research - PoC® Services | Covance
Drug Development Product Value Solutions | Covance
Molecule Development Group | Covance
Alliance Management Pharmaceutical Consulting | Covance
Phase IV Studies | Covance
Pharmaceutical Research and Drug Development | Covance
Molecule Development Group
Preclinical CRO, Studies and Testing | Covance Nonclinical
Complete PoC®
Molecule Development Group
Demonstrating Your Product Value
Preclinical CRO Testing Labs & Facilities | Covance Nonclinical
Shanghai Facility | Covance
Ann Arbor, MI Facility | Covance
Harrogate, UK Facility | Covance
Madison, WI Facility | Covance
Phase I Clinical Trials through Phase III Clinical Trials | Covance
Demonstrating Your Product Value
Molecule Development Group
Covance MarketPlace – Find the Right Partner for Your Drug Development Program | Covance
Early Phase Drug Development Solutions | Covance
Covance Drug Development Services
Drug Development Therapeutic or Specialty Areas | Covance
Cardiovascular Disease Drug Development | Covance
Dermatology Drug Development | Covance
Diabetes, Endocrinology and Nephrology | Covance
Infectious Diseases Drug Development
Infectious Diseases Education Center | Covance
Inflammation Drug Development Solutions
Inflammation Education Center
Rheumatoid Arthritis Drug Development Solutions | Covance
Respiratory Drug Development Solutions | Covance
NASH Liver Disease Drug Development | Covance
NASH Education Center
Neuroscience Drug Development | Covance
Oncology & Hematology Drug Development | Covance
Immuno-Oncology Drug Development Solutions | Covance
Immuno-Oncology Education Center
Oncology Education Center
Preclinical Pharmacology Oncology
Orphan Drug Development for Rare Diseases | Orphan Disease Testing
Orphan Disease Education Center | Covance
Rare Diseases Drug Development Solutions and Clinical Trials | Covance
Preclinical and Clinical Ophthalmic CRO Solutions | Covance
Pediatric Drug Development Solutions
Global contract research organization | Covance
Drug Development Services Australia | Covance
Complete PoC®
Life Cycle Management
Drug Development Services China | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Hong Kong | Covance
Complete PoC®
Life Cycle Management
Drug Development Services India | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Japan | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Korea | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Malaysia | Covance
Complete PoC®
Life Cycle Management
Drug Development Services New Zealand | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Philippines | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Singapore | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Taiwan | Covance
Complete PoC®
Life Cycle Management
Drug Development Services Thailand | Covance
Complete PoC®
Life Cycle Management
Drug Discovery and Development - By Molecule Type | Covance
Biologics Solutions | Drug Development | Covance
Small Molecule Drug Discovery and Development
Biosimilars Development Solutions
Biosimilars Education Center
Cell and Gene Therapy Solutions | Covance
Healthcare
Healthcare Commercialization Services | Covance
Patient Services and Provider Services | Commercialization | Covance
Patient Assistance Programs | Covance
Patient Access Programs 2020 Events
Patient Assistance Solutions | Covance
Pharmacy Services | Healthcare Commercialization | Covance
Clinical Patient Help and Services | Covance
Adherence in Healthcare | Covance
Healthcare Technology | Covance
Patient Access Programs 2020 Events
Market Access Consulting | Healthcare Commercialization | Covance
Managed Markets Services | Healthcare Commercialization | Covance
Informatics
Clinical Trial Optimization | Xcellerate® by Covance
Oncology Drug Development: Preclinical & Clinical | Covance
Preclinical Oncology CRO | Covance
Oncology Cell Lines | Covance Preclinical
786-O-LUC-NEO (RESCUED)
E.G7-OVA: Murine Thymic Lymphoma
SW 780 Human Bladder Carcinoma
NHDF (normal human dermal fibroblasts)
OVCAR-4
OVCAR-5: Human Ovarian Carcinoma
NCI-H446
NCI-H3122: Human Lung Adenocarcinoma
NCI-H929-Luc-mCh-Puro Human Multiple Myeloma
RAMOS-LUC
PANC-1-LUC
Pan02: Murine pancreatic ductal adenocarcinoma
OVCAR-8: Human Ovarian Carcinoma
NCI-H460 Human Lung Carcinoma
UACC-62
U-87 MG-Luc: Human glioblastoma
SW-480: Human Colon Carcinoma
SW-620: Human Colon Carcinoma
NCI-H295R
SF-539
SU-DHL-10 Human Large Cell Lymphoma
NCI-N87: Human Gastric Carcinoma
Reh (pMMP-Luc-Neo) Human B Cell (Acute Lymphocytic) Leukemia
Raji-luc: Human B-Cell Lymphoma
Ramos: Human B-cell Lymphoma
U-251-luc-mCh-Puro: Human Glioblastoma
SNU-5 Human Gastric Carcinoma
RIF-1: mouse sarcoma
SJSA-1 Human Osteosarcoma
PC-3M-Luc-C6 (Peritibial)
PC-3M-Luc-C6 (Orthotopic)
PC-3M-Luc-C6 (Intracardiac)
PC-3
PANC-1: Human Pancreatic Carcinoma
SK-OV-3-LUC-D3 (INTRAPERITONEAL)
SK-OV-3 (SUBCUTANEOUS)
OVCAR-8-Luc-mCh-Puro
Neuro-2a
RPMI 8226
YUMM1.7: Murine Melanoma
SK-MEL-28
ZR-75-1: Human Mammary Carcinoma (w/estradiol)
UISO-BCA-1
PC-9
NCI-H292
THP-1
NCI-H322M
NCI-H441
NCI-H460-LUC2
NCI-H508
NCI-H522
NCI-H23: Human Non-Small Cell Lung Carcinoma
NCI-H2122
NCI-H2110
NCI-H1975-LUC
NCI-H1975 Human Non-Small Cell Lung Carcinoma
NCI-H1703-LUC-MCH-PURO
NCI-H1703
NCI-H1650
NCI-H1299
NCI-H125-LUC
NCI-H125
NAMALWA
NALM6-Luc: Adult B Acute Lymphoblastic Leukemia
NALM6
MX-1-LUC
MX-1: Human Mammary Carcinoma
MV-4-11-Luc-mCh-Puro: Human Acute Meylogenous Leukemia
MV-4-11
MOLT-4-LUC-MCH-PURO
MOLT-4
MOLM-13
MMTV-PYMT
MM.1S (pMMP-Luc-Neo): Human Plasma Cell Myeloma
MKL-1
MIA PACA-2-LUC
MIA PaCa-2: Human Pancreatic Ductal Adenocarcinoma
MG-63
MDA-MB-468
MDA-MB-453
MDA-MB-435S
MDA-MB-361
MDA-MB-231-LUC-D3H3
MDA-MB-231-Luc-D3H2LN: Human Mammary Carcinoma
MDA-MB-231-LUC-D3H2
MDA-MB-231-LUC-D3H1
MDA-MB-231-2LMP
MDA-MB-231: Human Mammary Carcinoma
MCF7-LUC-MCH-PURO
MCF 10A
MCF-7
MC38: Murine Colon Adenocarcinoma
MBT-2
MB49-LUC-MCH-PURO
MB 49: Murine Bladder Cell Carcinoma
MB-1
M14
M059K
M-NFS-60
LS411N
LS 174T
LOX-IMVI: Human Melanoma
LOVO-6-LUC1
LOVO
LNCAP CLONE FGC
LN-229
LN-18
LN-827 (PMMP-LucNeo): Human Glioma
LL/2-LUC-M38
LL/2
Lewis Lung: Mouse Lung Carcinoma
L1210
KP4: Human Pancreatic Ductal Carcinoma
Kg-1-Luc-mCh-Puro: Human Leukemia (AML)
KB
Kasumi-3-Luc-mCh-Puro: Human Leukemia (AML)
Kasumi-3
Kasumi-1 Human Acute Myeloblastic Leukemia
KARPAS 299
K-562-LUC2
K-562
Jurkat-Clone E6-1
Jurkat: Human Lymphoblastic Leukemia
JJN-3-LUC-G418R
J82
J774A.1
J558-Luc-mCh-Puro
IGROV1: Human Ovarian Carcinoma
ID8-Luc: Murine Ovarian Carcinoma
ID8
HUT 78
HT-29-LUC
HT-29: Human Colon Carcinoma
HT-1376
HT-1080
HT
HS 895.T
HS 895.SK
HS 578T
HS 578BST
HL-60
HEPA 1-6-LUC-MCH-PURO
Hepa 1-6
HEP G2
Hep-55.1C-Luc-Mch-Puro
Hep-55.1C
Hep 3B2.1-7: Human Hepatocellular Carcinoma (HCC)
HELA
Hel-Luc-Neo
Hel 92.1.7-Luc-Neo
Hel 92.1.7
Hel
HEKN (Human Epithelial Keratinocytes)
Hek 293-Luc-mCh-Puro
Hek 293
HCT-8
HCT-15
HCT-116-LUC
HCT-116: Human Colon Carcinoma
HCC827-LUC-MCH-PURO
HCC827
HCC70: Human Triple Negative Mammary Carcinoma
HCC2998
HCC1395
GRANTA-519
GLI36-DSRED-R-LUC (RESCUED)
GL261-Luc2: Mouse Glioma
GL261
GIST-T1: Human Gastrointestinal Stromal Tumor
G-361
FARAGE
FaDu: Human Pharyngeal Squamous Cell Carcinoma
EOL-1
EMT-6 Murine Mammary Carcinoma
EBC-1
E0771: Murine Mammary Carcinoma
DU 145-LUC
DU 145: Human Prostate Carcinoma
DND-41-LUC-MCH-PURO
DMS 114
DLD-1: Human Colon Carcinoma
DBTRG (TUMOR)
DBTRG-05MG
DB/M2
DB
Daudi-luc-mCh-Puro: Human B-Cell Lymphoma
DAUDI
D54-Luc: Human Glioma
CWR-22-R
CT26.WT: Murine Colon Carcinoma
COS-7
COLO 829: Human Melanoma
COLO 205-LUC #2
COLO 205: Human Colon Carcinoma
CCRF-CEM
CAPAN-2
CAPAN-1
Calu-6: Human Lung Adenocarcinoma
CALU-3
CALU-1
CAL 27: Human Tongue Squamous Cell Carcinoma
CAKI-1
CACO-2
C51: Mouse Colon Carcinoma
C2BBE1
C26: Mouse Colon Carcinoma
C1498-Luc: Murine Leukemia
C1498
BXPC-3-LUC2
Bx-PC-3: Human Pancreatic Carcinoma
BT142: Human Oligoastrocytoma (Glioma)
BT-474: Human Mammary Invasive Ductal Carcinoma
BT-20
BNL 1ME A.7R.1-LUC-MCH-PURO
BNL 1ME A.7R.1
BEWO
B16-F10-Luc2: Murine Melanoma
B16-F10-LUC-G5
B16-F10: Murine Melanoma
B-JAB
ARH-77
ACHN Human Renal Carcinoma
AB1-LUC-MCH-PURO
AB1
A549-LUC-C8
A549: Human Lung Carcinoma
A375: Human Melanoma
A2780-LUC
A2780
A2058
A20-LUC2-PURO
A20 Murine B Cell Lymphoma
A-673
A-498 Human Renal Carcinoma
A-431
786-O
769-P
5TGM1-Luc: Murine Multiple Myeloma
4T1-LUC2: Mouse Mammary Carcinoma
22RV1
P388D1-Luc
NCI-H596
NCI-H69
NCI-H82
NCI-H929
NIH:OVCAR-3
NIH:OVCAR-3-LUC-MCH-PURO
NK-92MI
NOMO-1
NUGC-4
OCI-LY1 LN
OCI-LY19-LUC-NEO
OCI-LY3-LUC-MCH-PURO
OCI-LY7-LUC-MCH-PURO (RESCUED)
OCI-LY7-LUC-NEO
OCM-1
OCM-1-LUC-MCH-PURO
OE33
OPM-2
OV-90
OVCAR-5-LUC-MCH-PURO
P388
P815
PA-NUT
PAN02.TD1-LUC-MCH-PURO
PC-3-LUC
PAN03
Human Cancer Cell Lines and Growth Curves
OVCAR-3 (PMMP-LUC-NEO): Human ovarian carcinoma – Intra-bursa
OVCAR-3 (PMMP-LUC-NEO): Human ovarian carcinoma – IP
SW 1990
NCI-H1299-Luc: Human Large Cell Lung Carcinoma
Pfeiffer
B16
Raji
Raw-264-7
Reh
Renca
RL
SF-295
Saos-2
SF-767
SHP-77
SK-BR-3
SK-LMS-1
SK-MEL-28-Luc-mCh-Puro
SK-MEL-5
SK-MES-1
SK-N-AS
SK-N-FI
SK-N-SH
SNB-19
SU-86.86
SU-DHL-10-LN-HIGH
SU-DHL-16
SU-DHL-4-LUC-MCH-PURO
SU-DHL-6
SU-DHL-6-LUC-MCH-PURO
SU-DHL-8
SW 872
T24
T24-LUC-NEO
T24P
T47D
TE 353.SK
TK-10
TOLEDO-LUC-NEO
U-251
U266B1
VCAP
WM-115
WSU-DLCL2
WSU-FSCCL
YAC-1
TF-1A-LUC-NEO
WALKER256
5637
HepG2
Oncology and Immuno-oncology Tumor Models | Covance Preclinical
Subcutaneous Tumor Models
Orthotopic Models | Covance Preclinical
Metastasis Models | Covance Preclinical
Disseminated Models | Covance Preclinical
Adoptive Cell Therapies & CAR T | Covance Preclinical
In Vitro Oncology | Covance Preclinical
Immunohistochemistry | Covance Preclinical Oncology
Protein Expression Analysis
DNA / RNA Expression Analysis
Cell Processes
Cell and Tissue Processing
Cell Culture
Blood and Plasma Analysis
786-O (pMMP-LucNeo) – A model for renal cell carcinoma
GL261: Syngeneic murine glioma model
CT26: Murine colon carcinoma
5TGM1-luc – A syngeneic murine model for multiple myeloma
MDA-MB-231-luc-D3H2LN: A valuable model for triple-negative breast cancer research
Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation
A deeper dive into the tumor-infiltrating T Cell immunophenotype
Comprehensive dendritic cell analysis by flow cytometry using the new CompDC™ panel
Multiplex IHC for patterns of protein expression, co-expression, and spatial relationships
Phospho-protein detection in solid tumors using phospho-flow cytometry
A20: Modeling B cell lymphoma in mice
Subcutaneous and systemic preclinical modeling of A20 murine B cell lymphoma
C1498-Luc-mCherry: A syngeneic acute myeloid leukemia (AML) model
C1498: A murine model for acute myelogenous leukemia (AML)
Colo-205 as a translational imaging model for colorectal cancer
HCC70: A model of triple negative breast cancer
Syngeneic model for preclinical evaluation of ovarian cancer
ID8: A syngeneic mouse model for testing ovarian cancer immunotherapies
MC38: An immunoresponsive murine tumor model | Covance
Focal radiation in the murine 4T1-luc2 mammary cancer model
A549 – A model for non-small cell lung cancer
MV(4;11): A model of human AML (acute myeloid leukemia)
PC-3M-Luc-C6 – a model for prostate carcinoma
E0771 Syngeneic Breast Cancer Model
EMT-6 syngeneic breast tumor model – a powerful tool for immuno-oncology studies
Hepa 1-6: A murine model of hepatocellular carcinoma
Targeting B Cell malignancies? Raji-Luc is a model to test CD19-directed CAR-T cells and other novel approaches
ID8 syngeneic ovarian cancer model response to checkpoint inhibitors
HT-29 as a preclinical model for colorectal cancer
GL261-luc: A model for immunotherapy and radiation therapy
Pan02: A murine model of pancreatic cancer | Covance
4T1-luc2: An orthotopic mammary cancer model to support novel immuno-oncology drug discovery
Prostate cancer modeling with PC-3: One model, four applications
MB49 – a bladder cancer murine tumor model
PyMT – a transplantable murine model of breast cancer
Modeling immuno-oncology in a humanized mouse
Modeling human acute lymphoblastic leukemia (ALL) – using the NALM6-Luc-mCh-Puro model for the development of CAR T cell therapies
Models for non-small cell lung carcinoma
Models for non-small cell lung carcinoma - part 2
LL/2: an immunosuppressive murine tumor model
B16-F10: a murine melanoma model | Covance
Modeling liver cancer with syngeneic hepa 1-6: an update
Pan02 – pancreatic ductal adenocarcinoma model characterized for immuno-oncology applications
MM.1S: A model for multiple myeloma
NCI-H2228 – usage of DCE MRI in a non-small cell lung cancer orthotopic brain metastatis model
Models for pancreatic cancer
Measuring Tumor Antigen-Specific Immunity Through ELISpot and FluoroSpot
Reconstructed Bone, plate-based 3D culture assay
BT-474 Human ductal breast carcinoma: New life for an old model
Update on the preclinical use of hPBMC for immuno-oncology modeling
Functional Analysis of Tumor Infiltrating Lymphocytes by Flow Cytometry Using the Cytokine/Cytotoxicity™ Panel
Bioluminescence imaging: In vivo monitoring of tumor development, disease dissemination and treatment efficacy
Pan02-Luc: An orthotopic model of pancreatic cancer
Determining preclinical CAR T-cell persistence by flow cytometry
CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies
Preclinical Oncology: 2020 Spotlight Roundup | Covance
EMT6-Luc: In vivo monitoring of metastatic development and treatment efficacy
Oncology Posters | Covance Preclinical
Systemic and subcutaneous modeling of A20 murine B cell lymphoma in mice: A comparative assessment
Focal radiation enhances paclitaxel therapy in a mouse model of triple negative breast cancer
ID8-Luc syngeneic ovarian cancer model for preclinical evaluation of immunomodulatory molecules
Combined focal radiation and anti-mCTLA-4 antibody therapy modulates myeloid subset phospho-stat3 levels in the 4T1 tumor microenvironment, and results in tumor growth inhibition
High-throughput analysis of MAPK and JAK-STAT signaling in CT26 tumors using a combination of immunophenotyping and phospho-flow cytometry
Characterization of proliferation in multiple lymphocyte subsets in the CT26 murine colon carcinoma model by multi-color flow cytometry
Combination of a glycomimetic antagonist to E-selectin and CXCR4, GMI-1359, with an anti-PD-L1 antibody attenuates regulatory T Cell infiltration and accelerates time to complete response in the murine CT26 tumor model
In-depth myeloid cell characterization in the murine syngeneic CT.26 colon carcinoma model by 10-color flow cytometry
Comprehensive 10-color flow cytometry analysis of the neuroblastoma intratumoral immune response using the murine syngeneic Neuro-2a tumor model
Preclinical models of multiple myeloma
Radiation enhances anti-tumor activity of checkpoint blockade in syngeneic tumor models
Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
Sensitivity of syngeneic tumor models to focal radiation
Combination of rapamycin with immune checkpoint blockade in a syngeneic breast carcinoma model
Image-guided focal irradiation in syngeneic preclinical oncology mouse models
Anti-mCTLA-4 treatment results in early and late immune response effects in a murine model of colorectal carcinoma
Preclinical use of focal radiation and immune checkpoint blockade to improve therapeutic response in an immunologically cold tumor
Evaluation of the immune response following treatment with anti‐CTLA‐4 antibody, radiation therapy or the combination in a murine model of breast cancer
Combined dynamic 18F-FDG PET imaging and DCE prediction of treatment response in an orthotopic model of glioblastoma multiforme
Radiation response in preclinical orthotopic models of brain cancer
Evaluation of immunomodulatory agents in classically immunologically “cold” cancers using syngeneic mouse models of breast and ovarian cancer
Preclinical response of murine syngeneic tumor models to immune checkpoint inhibitor antibodies
A comparative evaluation of immunotherapy responses in murine colon carcinoma
Imaging the future | Published in the European Biopharmaceutical Review
TIGIT directed human antibody modulates T-regulatory and effector cell function
Oncology & Hematology Clinical Trial Development | Covance
Meet the Oncology & Hematology Medical Consulting Team | Covance
Patient Recruitment | Covance
Immuno-Oncology & Immunotherapy CRO | Covance Preclinical & Nonclinical
Preclinical Immunotherapy CRO | Covance
Immuno-Oncology Clinical Trial Development CRO | Covance
Oncology Treatment Development Resources | Covance CRO
Top 5 Design Considerations for Preclinical Immuno-oncology Studies
Top 5 Models for Immuno-oncology Studies
Oncology & Immuno-oncology Events | Covance
Precision Medicine Applications in Oncology Webinar Series | Covance
Webinars
IND/CTA Enabling Studies
Lung, Respiratory and Pulmonary Development | Covance
In Vivo & In Vitro Respiratory Disease Models | Covance Nonclinical
Respiratory & Lung Disease | Covance Clinical Trials
Lung, Respiratory, Pulmonary and Inhalation Resources | Covance
Inhalation RD
Device RD
Global CRO Drug Development Services | Covance
Lead Optimization Non-GLP Toxicology
Computed Tomography (CT) Services
Flow Cytometry Services
Drug Analysis Services
Bioanalytical Laboratory Solutions & Services
LC-MS Immunoanalytical Solutions
Bioanalytical Method Development & Validation
Preclinical and Clinical Sample Analysis
Immunoanalytical Solutions
Microfluidics
Specialty LC-MS Support
Targeted Proteomics
Discovery Bioanalysis
Vaccine Analysis
Analytical Methods for Bioanalysis
Bioanalysis Education Center
Drug Metabolism and Pharmacokinetics (DMPK), Including ADME Studies | Covance
In Vitro Metabolism Services | Covance Nonclinical
Enzyme Induction Services | Covance Nonclinical
Enzyme Inhibition Services | Covance Nonclinical
Metabolic Stability Studies & Services | Covance Metabolism
Metabolism Protein Binding Studies & Services | Covance Preclinical
Reaction Phenotyping Studies & Services | Covance Preclinical
Drug Transporter Interactions & Drug-Drug Interactions (DDIs) | Covance Metabolism
In Vivo Metabolism Services & Studies | Covance Nonclinical
Metabolite Identification Studies & Services | Covance Metabolism
Human AME (hAME) Studies | Covance Metabolism
Metabolism & Pharmacokinetic Events | Covance
Modeling, In Silico and Pharmacometric Studies | Covance Nonclinical
Compartmental PK Analysis & Modeling | Covance
PK/PD Modeling & Simulation Services | Covance Nonclinical
PBPK Analysis & Modeling | Covance
Quantiative and/or Systems Pharmacology (QSP / SP) Modeling | Covance
Custom Antibody Reagents
Lead Optimization Services
Lead Optimization Non-GLP Toxicology
Core Lead Optimization Toxicology Services
Safety Assessment Non-GLP Toxicology
In Vivo Pharmacology & Disease Model Development
Comprehensive Leukocyte Quantitation
Oncology Cell Line Assays
PK Study & PK/TK (Pharmacokinetics & Toxicokinetics) Analysis and Reporting
Nonclinical Imaging Services
Computed Tomography (CT) Services
Bioluminescence Imaging
Image Analysis Services
Positron Emission Services
Radiation Nonclinical CRO Services
Flow Cytometry Services
Vaccine Discovery Testing
Crop & Chemical Product Testing
Crop Protection Product Testing
Crop Protection Education Center
Human Safety - Toxicology
Developmental and Reproductive Toxicology (DART)
Genetic Toxicology
In Silico
In Vitro Alternative Test Methods
General Toxicology
Regulatory Consultancy
Registration and Submission
Classification Labeling and Safety Data Sheets
Biocides
Regulations
Biocide Regulation in Europe
Authorization of biocidal products in Europe
Endocrine Disruptors
Endocrine Disruptor (ED) Testing across the World
Regulatory Support for Endocrine Disruptors
Physical Chemistry
Physicochemical Properties of Active Ingredients
Physicochemical Properties and Technical Characteristics of Formulated Products
Environmental Safety
Ecotoxicology
Aquatic Ecotoxicology
Terrestrial Ecotoxicology
Environmental Fate and Metabolism
Environmental Fate
Radiosynthesis
Comparative In Vitro Metabolism
Plant Metabolism
Animal Metabolism
Livestock Metabolism Studies
Lab Animal Metabolism
Dermal Absorption
Field Trials
Residue Analysis Services (RAS)
Locations
Chemical Testing
Physical Chemistry
Human Safety - Toxicology
Developmental and Reproductive Toxicology (DART)
Genetic Toxicology
Inhalation Toxicology
In Silico
In Vitro Alternative Test Methods
General Toxicology
Environmental Safety
Ecotoxicology
Aquatic Ecotoxicology
Terrestrial Ecotoxicology
Environmental Fate and Metabolism
Environmental Fate
Laboratory Animal Metabolism (Toxicokinetics)
Radiosynthesis
Endocrine Disruptors
Regulatory Consultancy
Regulatory Support for All Global Regulations
EU Reach
Only Representative
Brexit
UK REACH
US Toxic Substances Control Act (TSCA)
Other Global Chemical Regulations
K-REACH
Classification Labeling and Safety
Registration and Submission
Chemical Testing Education Center
Locations
Crop Protection & Chemical Sites | Covance
Shanghai Facility | Covance
Ann Arbor, MI Facility | Covance
Madison, WI Facility | Covance
Harrogate, UK Facility | Covance
Denver, PA Facility | Covance
Eye, UK Facility | Covance
Greenfield, IN Location | Covance
Huntingdon, UK Facility | Covance
Münster, GD Facility | Covance
Shardlow, UK Facility | Covance
Somerset, NJ Facility | Covance
Toxicologic Pathology | Covance Preclinical CRO
Anatomic Pathology CRO Services | Covance
Clinical Pathology | Covance Preclinical CRO
Specialty Pathology Techniques | Covance Preclinical CRO
Immunohistochemistry (IHC) Services | Covance Nonclinical
Electron Microscopy (TEM) | Covance Nonclinical
Chemistry, Manufacturing and Controls (CMC) Support
Biopharm CMC Manufacturing Solutions | Covance
BIOCMC Analytical Solutions Education Center
Toxicology: Safety Assessment | Covance
General Toxicology | Covance
SEND - Standard for the Exchange of Nonclinical Data | Covance
Core Toxicology Services | Covance
Drug Abuse Liability Solutions | Covance
Infusion Toxicology Services | Covance
Juvenile Studies | Covance
Neurotoxicity Studies | Covance
Nonhuman Primate Studies | Covance
Ocular Development Services | Covance
Genetic Toxicology Studies | Safety Assessment | Covance
Regulatory Assays | Genetic Toxicology | Covance
Genetic Toxicology Screening Studies | Covance
Multi-endpoint Genetic Toxicology Assays | Covance
Immunotoxicology | Drug Development Services | Covance
Safety Pharmacology | Covance Preclinical CRO
Safety Pharmacology | Cardiovascular Assessment | Covance
Safety Pharmacology | ICH Core Battery Tests | Covance
Safety Pharmacology | ICH Studies and Supplemental Tests | Covance
Safety Pharmacology | Drug Discovery Support | Covance
Safety Pharmacology | Neurotoxicology Study Services | Covance
Safety Pharmacology | Infusion Safety Pharmacology Services | Covance
Drug Abuse Assessment Education Center
Developmental and Reproductive Toxicology | Covance
SEG I: Fertility and Early Embryonic Development | Covance
SEG II: Embryo Fetal Development | Covance
SEG III: Prenatal and Postnatal Development | Covance
EPPND: Enhanced Pre- and Post-Natal Development Services | Covance
Juvenile Toxicity Studies | Covance
Special Evaluation Techniques | Covance
Infusion Services | Covance
SEND 3.1 Standard for the Exchange of Nonclinical Data | Covance
SEND Education Center
Routes of Administration | Covance Nonclinical
Inhalation Toxicology | Covance Nonclinical
Pharmaceutical Consulting | Covance
Molecule Development Group
Alliance Management
Molecule Development Group | Consulting Services | Covance
Drug Development Alliance Management Consulting | Covance
Early Phase Development Solutions | Covance
MarketPlace
Drug Development Consulting | Covance
Access & Strategy
Evidence Generation
Xcellerate
Data Capabilities
Design Better Studies | Xcellerate - Covance
Improve Study Recruitment | Xcellerate - Covance
Reduce Study Risk | Xcellerate - Covance
Gain Operational Insights | Xcellerate - Covance
Ensure Data Quality | Xcellerate - Covance
Access Central Laboratory Information | Xcellerate - Covance
Empower Your Data | Xcellerate - Covance
Maximize Product Access | Xcellerate - Covance
Transform Patient Safety | Xcellerate - Covance
GlobalCODE®
Clinical Development Services | Covance
Clinical Pharmacology / Phase I in Drug Development | Covance
Clinical Pharmacology Education Center | Covance
Early Clinical Development Phase (IIa) | Covance
Clinical Research Unit Virtual Tours | Covance
Phase IIb Clinical Trials/Phase III Clinical Trials
Clinical Data Management Analysis and Reporting | Covance
Global Regulatory Affairs & Product Development Consulting | Covance
Phase IV | Covance
Virtual Clinic Tours
Clinical-Biotech | Covance
Decentralized Clinical Trials | Covance
Decentralized Clinical Trials (DCT) Education Center | Covance
Clinical Trial Laboratory Services | Covance
Clinical Laboratory Services | Covance Central Labs
Companion Diagnostics
Asia Pacific
Europe, Middle East and Africa
United States, Canada and Puerto Rico
Latin America
SpecimINSIGHT™/GlobalCODE® – Pipeline Data Management Solutions Powered by Global Specimen Solutions®
Patient Service Centers
Discover Unrealized ROI With GlobalCODE® End-to-End Specimen Management
Specialty Testing
Flow Cytometry Solutions | Covance
Translational Biomarker Solutions | Covance
Vaccines and Immunology | Covance
Assays to Support Vaccines and Novel Immunotherapeutics
Vaccines Education Center | Covance
Expanded Lab Management Solutions
Precision Medicine Solutions
Biomarker Solutions, Designed Around You | Covance
Biomarker Solution Center | Covance
Companion Diagnostics (CDx) - Clinical Testing Services | Covance
Genomics Services
Cell and Gene Therapy Solutions | Covance
Cell and Gene Therapy Expert Teams | Covance
Cell Therapies | Covance
Gene Therapies | Covance
Immuno-Oncology
Preclinical Immunotherapy CRO | Covance
Immuno-Oncology Clinical Trial Development CRO | Covance
Bioanalytical Services
Analytical Methods for Bioanalysis
Bioanalysis Education Center
CMC Analytical
BIOCMC Analytical Solutions Education Center
Alliance Management
Assays to Support Vaccines and Novel Immunotherapeutics
Vaccines Education Center | Covance
Functional Service Provider Model: Covance FSPx
Functional Service Provider Model: Covance FSPx Education Center
Drug Commercialization and Pharma Services | Covance
Patient Support Programs
Access and Strategy | Covance Market Access
Evidence Generation | Covance Market Access
Value Communication | Covance Market Access
Patient Support Services | Covance Market Access
Patient Assistance Programs
Field Services | Covance Market Access
Covance Market Access - Asia-Pacific
Access and Strategy
Evidence Generation
Value Communication
Patient Support Services | Covance
Patient Access Programs 2020 Events
Phase IV Solutions
Patient Safety and PV Services (Pharmacovigilance): From Adverse Events to Signal Detection and Risk Management | Covance
PV Services | Covance
Aggregate Reporting and Safety Writing | Covance
Signal Detection Pharmacovigilance and PV Risk Management | Covance
Patient Safety Consulting for Drug and Medical Development | Covance
Integrated Drug Safety Technology Solutions | Covance
Patient Safety Solutions Resource Center | Covance
Pharmacovigilance Automation
Biomarker Solutions, Designed Around You | Covance
Clients
Solutions Designed Distinctly for the Nimble and Progressive Biopharma Venture
Partner
Approach
Value
Transition
Contact
The Hub - Designed Around You | Covance
Take on Evolving Drug Development Challenges with Partnership Designed Around You
®
Clinical Trial Investigators | Covance
Dry Ice
Order a Kit | Covance
Become a Clinical Trial Investigator | Covance
Accreditations and Certifications | Covance
Current Investigator & Study Staff | Covance
Courier Contact Numbers
UPS Express Critical Label
Dry Ice
Institution Privacy Statement
Investigator Privacy Statement
Study Staff Privacy Statement
Packaging and Shipping Videos
Sample Collection Videos
Frequently Asked Questions
Participate in a Trial
Covance Medical Device & Diagnostic Solutions
Our Approach
Regulatory & Consulting
Preclinical and Experimental Surgery Solutions
Clinical & Market Approval
Commercial & Post-Market Support
Medical Device Education Center | Covance
Consultant Connection | Covance
Device
Latest Thinking
Blog
Resources: Scientific & educational insights on pharmaceutical & product development | Covance
KL Detail
KL Search Page Custom
About Us
About Covance
Corporate Responsibility | Covance
Our Commitment as Insightful CRO Partners | Covance
Our Commitment as Relentless CRO Collaborators | Covance
Animal Welfare
Code of Respect
Our Commitment to Animal Welfare
Why Animal Research
Impact on Results
Beliefs in Action
Brexit Update | Covance
Contact Us
Unsubscribe
Unsubscribe Confirmation
Covance Preference Center
Upcoming Events and Webinars
Covance Webinars
Scientific Symposiums
Events Twitter Feed
Connect with Us at SCOPE, March 2-4
Design Better Studies | Covance
Xcellerate Protocol Design Tool | Covance
Xcellerate Patient Intelligence | Covance
Improve Study Recruitment | Covance
Xcellerate Recruitment Analysis & Forecasting | Covance
Xcellerate Site List Tool | Covance
Xcellerate Spatial Cluster Analysis | Covance
Reduce Study Risk | Covance
Xcellerate Risk Assessment & Categorization Tool | Covance
Xcellerate Risk & Issue Management | Covance
Xcellerate Risk Review | Covance
Gain Operational Insights | Covance
Xcellerate Action Alerts
Xcellerate CRA Dashboard
Xcellerate Study Dashboard
Xcellerate Portfolio Dashboard
Ensure Data Quality | Covance
Xcellerate Medical Review
Xcellerate Statistical Review
Xcellerate Data Review
Access Central Lab Information | Covance
Xcellerate Lab Sponsor Portal
Xcellerate LabLink+
Xcellerate Lab Investigator Portal
Empower Your Data | Covance
Xcellerate Clinical Data Warehouse
Xcellerate Operational Data Warehouse
Maximize Product Access | Covance
Xcellerate Patient Access Toolkit | Covance
Xcellerate Patient Support BI Dashboard | Covance
Transform Patient Safety | Covance
Xcellerate Case Management
Xcellerate Safety Reporting
Covance Business Unit Names New Leaders
COVID-19 Vaccine Development | Covance
COVID-19 Vaccine & Antiviral Preclinical Development and Testing | Covance
COVID-19 Trial Design & Patient Recruitment | Covance Clinical
COVID-19 Clinical Testing & Labs | Covance
COVID-19 Treatments: Commercialization & Reimbursement | Covance
COVID-19: Medical Device and Diagnostic Solutions | Covance
COVID-19 Product Testing for Crops or Chemicals | Covance
Coronavirus (COVID-19) Updates | Covance
COVID-19 Clinical Trial Connect | Covance